“Accelerating Stem Cell Treatments” Featuring Dr. Maria Millan
On this episode of the Stem Cell Podcast, Dr. Maria Millan from the California Institute for Regenerative Medicine (CIRM) talks about her transition from surgeon to stem cell specialist, how California culture has helped CIRM to thrive, and its role in training the next generation of stem cell scientists.
Scaling Biomimetic Culture of Pluripotent Stem Cells
Hear from Dr. Maxime Feyeux, who discusses what the in vivo growth environment of pluripotent stem cells (PSCs) can teach us about in vitro culture. He summarizes some of the current challenges facing standard PSC culture technologies and shares a solution for mass producing high-quality PSCs for downstream applications.
Next-Generation Cell Isolation Solutions for T Cell Therapy Research
Join this talk, presented by Dr. Amanda Durkin and Q&A guest Dr. Frann Antignano, to learn about STEMCELL’s cell isolation solutions for fast and easy T cell isolation. This presentation will also focus on large-scale research strategies by introducing our new mobilized leukopaks and feature the Easy 250 EasySep™ Magnet—a scalable and efficient system for manual column-free isolation.
Combining CAR T Cells with STING Agonists to Fight Solid Tumors
In this webinar, Dr. Uslu describes how IMSA101 enhances CAR T function through STING agonist-induced IL-18 secretion and how these findings lay the foundation for advancing the combinatorial approach into a clinical setting.
“Developing Regenerative Medicines” Featuring Dr. Stefan Irion
On this episode of the Stem Cell Podcast, Dr. Stefan Irion from BlueRock Therapeutics discusses the company’s Parkinson’s disease trial and the challenges of genetically manipulating stem cells.
Daniel Gray, PhD
Dr. Daniel Gray describes his work studying cell death and the potential applications in drug development for immune disorders
EasySep™小鼠TIL（CD45）正选试剂盒
“Accelerating Stem Cell Treatments” Featuring Dr. Maria Millan On this episode of the Stem Cell Podcast, Dr. Maria Millan from the California Institute for Regenerative Medicine (CIRM) talks about her transition from surgeon to stem cell specialist, how California culture has helped CIRM to thrive, and its role in training the next generation of stem cell scientists.
Production of Chimeric Antigen Receptor T Cells This free Nature Protocols Wallchart summarizes the processes involved in producing CAR T cells for therapy.
How to Set Up an Assay with the hPSC Genetic Analysis Kit Experiment Analyze genomic DNA samples using the Human Pluripotent Stem Cell (hPSC) Genetic Analysis Kit
Scaling Biomimetic Culture of Pluripotent Stem Cells Hear from Dr. Maxime Feyeux, who discusses what the in vivo growth environment of pluripotent stem cells (PSCs) can teach us about in vitro culture. He summarizes some of the current challenges facing standard PSC culture technologies and shares a solution for mass producing high-quality PSCs for downstream applications.
Next-Generation Cell Isolation Solutions for T Cell Therapy Research Join this talk, presented by Dr. Amanda Durkin and Q&A guest Dr. Frann Antignano, to learn about STEMCELL’s cell isolation solutions for fast and easy T cell isolation. This presentation will also focus on large-scale research strategies by introducing our new mobilized leukopaks and feature the Easy 250 EasySep™ Magnet—a scalable and efficient system for manual column-free isolation.
How EasySep™ Magnetic Cell Separation Technology Works: Fast and Easy Cell Isolation EasySep™ technology, a fast and easy immunomagnetic cell separation technology that allows you to isolate virtually any cell types from a variety of sample sources in as little as 8 minutes
Combining CAR T Cells with STING Agonists to Fight Solid Tumors In this webinar, Dr. Uslu describes how IMSA101 enhances CAR T function through STING agonist-induced IL-18 secretion and how these findings lay the foundation for advancing the combinatorial approach into a clinical setting.
“Developing Regenerative Medicines” Featuring Dr. Stefan Irion On this episode of the Stem Cell Podcast, Dr. Stefan Irion from BlueRock Therapeutics discusses the company’s Parkinson’s disease trial and the challenges of genetically manipulating stem cells.
Daniel Gray, PhD Dr. Daniel Gray describes his work studying cell death and the potential applications in drug development for immune disorders
